Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer

INTRODUCTION: Concurrent chemoradiotherapy (cCRT) was the standard of care for patients with unresectable stage III non-small cell lung cancer (NSCLC) prior to the PACIFIC trial, however, patients also received single modality therapy. This study identified predictors of therapy and differences in o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Bobbili, Priyanka, Ryan, Kellie, DerSarkissian, Maral, Dua, Akanksha, Yee, Christopher, Duh, Mei Sheng, Gomez, Jorge E.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080248/
https://ncbi.nlm.nih.gov/pubmed/32187231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230444
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires